Does RANOLAZINE Cause Chronic obstructive pulmonary disease? 69 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Chronic obstructive pulmonary disease have been filed in association with RANOLAZINE (Ranolazine). This represents 0.7% of all adverse event reports for RANOLAZINE.
69
Reports of Chronic obstructive pulmonary disease with RANOLAZINE
0.7%
of all RANOLAZINE reports
10
Deaths
26
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From RANOLAZINE?
Of the 69 reports, 10 (14.5%) resulted in death, 26 (37.7%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which RANOLAZINE Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ